Effectiveness of the actions of antimicrobial's control in the intensive care unit

Detalhes bibliográficos
Autor(a) principal: Santos,Edilson Floriano dos
Data de Publicação: 2003
Outros Autores: Silva,Antonio Emanuel, Pinhati,Henrique M. Sampaio, Maia,Marcelo de O.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Infectious Diseases
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702003000500002
Resumo: There are various strategies to improve the effectiveness of antibiotics in hospitals. In general, the implementation of guidelines for appropriate antibiotic therapy and the participation of infectious disease (ID) physicians deserve considerable attention. This study was a prospective ecological time-series study that evaluates the effectiveness of the ID physician's opinion to rationalize and control the use of antibiotics in medical-surgical intensive care units (ICU), and the impact of their intervention on treatment expenditures. There was significant change in the pattern of use of antimicrobials, this pattern approximating that of a medical-surgical ICU that participates in the ICARE (Intensive Care Antimicrobial Resistance Epidemiology) Project. For example, there was a significant increase in the consumption of antimicrobials of the ampicillin group (Relative Risk [RR]=3.39; 95% CI: 2.34-4.91) and antipseudomonal penicillins (RR=2.89; 95% CI: 1.70-4.92). On the other hand, there was a significant reduction in the consumption of 3rd/4th generation cephalosporins (RR=0.66; 95% CI: 0.57-0.77) and carbapenems (RR=0.43; 95% CI: 0.33-0.56). On average, for every patient-day antibiotic expense was reduced 37.2% during calendar year 2001, when compared with 2000. The ID specialists' opinion and the adoption of guidelines for empirical antibiotic therapy of hospital-acquired pneumonia contributed to a reduction in the use of antimicrobials in medical-surgical ICU. However, further studies that have more control over confounding variables are needed to help determine the relevance of these discoveries.
id BSID-1_efc5b867d7d59307422c6ffb47c51210
oai_identifier_str oai:scielo:S1413-86702003000500002
network_acronym_str BSID-1
network_name_str Brazilian Journal of Infectious Diseases
repository_id_str
spelling Effectiveness of the actions of antimicrobial's control in the intensive care unitAntibioticscost controlinfection controldrug resistancemicrobialThere are various strategies to improve the effectiveness of antibiotics in hospitals. In general, the implementation of guidelines for appropriate antibiotic therapy and the participation of infectious disease (ID) physicians deserve considerable attention. This study was a prospective ecological time-series study that evaluates the effectiveness of the ID physician's opinion to rationalize and control the use of antibiotics in medical-surgical intensive care units (ICU), and the impact of their intervention on treatment expenditures. There was significant change in the pattern of use of antimicrobials, this pattern approximating that of a medical-surgical ICU that participates in the ICARE (Intensive Care Antimicrobial Resistance Epidemiology) Project. For example, there was a significant increase in the consumption of antimicrobials of the ampicillin group (Relative Risk [RR]=3.39; 95% CI: 2.34-4.91) and antipseudomonal penicillins (RR=2.89; 95% CI: 1.70-4.92). On the other hand, there was a significant reduction in the consumption of 3rd/4th generation cephalosporins (RR=0.66; 95% CI: 0.57-0.77) and carbapenems (RR=0.43; 95% CI: 0.33-0.56). On average, for every patient-day antibiotic expense was reduced 37.2% during calendar year 2001, when compared with 2000. The ID specialists' opinion and the adoption of guidelines for empirical antibiotic therapy of hospital-acquired pneumonia contributed to a reduction in the use of antimicrobials in medical-surgical ICU. However, further studies that have more control over confounding variables are needed to help determine the relevance of these discoveries.Brazilian Society of Infectious Diseases2003-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702003000500002Brazilian Journal of Infectious Diseases v.7 n.5 2003reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1590/S1413-86702003000500002info:eu-repo/semantics/openAccessSantos,Edilson Floriano dosSilva,Antonio EmanuelPinhati,Henrique M. SampaioMaia,Marcelo de O.eng2004-01-22T00:00:00Zoai:scielo:S1413-86702003000500002Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2004-01-22T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false
dc.title.none.fl_str_mv Effectiveness of the actions of antimicrobial's control in the intensive care unit
title Effectiveness of the actions of antimicrobial's control in the intensive care unit
spellingShingle Effectiveness of the actions of antimicrobial's control in the intensive care unit
Santos,Edilson Floriano dos
Antibiotics
cost control
infection control
drug resistance
microbial
title_short Effectiveness of the actions of antimicrobial's control in the intensive care unit
title_full Effectiveness of the actions of antimicrobial's control in the intensive care unit
title_fullStr Effectiveness of the actions of antimicrobial's control in the intensive care unit
title_full_unstemmed Effectiveness of the actions of antimicrobial's control in the intensive care unit
title_sort Effectiveness of the actions of antimicrobial's control in the intensive care unit
author Santos,Edilson Floriano dos
author_facet Santos,Edilson Floriano dos
Silva,Antonio Emanuel
Pinhati,Henrique M. Sampaio
Maia,Marcelo de O.
author_role author
author2 Silva,Antonio Emanuel
Pinhati,Henrique M. Sampaio
Maia,Marcelo de O.
author2_role author
author
author
dc.contributor.author.fl_str_mv Santos,Edilson Floriano dos
Silva,Antonio Emanuel
Pinhati,Henrique M. Sampaio
Maia,Marcelo de O.
dc.subject.por.fl_str_mv Antibiotics
cost control
infection control
drug resistance
microbial
topic Antibiotics
cost control
infection control
drug resistance
microbial
description There are various strategies to improve the effectiveness of antibiotics in hospitals. In general, the implementation of guidelines for appropriate antibiotic therapy and the participation of infectious disease (ID) physicians deserve considerable attention. This study was a prospective ecological time-series study that evaluates the effectiveness of the ID physician's opinion to rationalize and control the use of antibiotics in medical-surgical intensive care units (ICU), and the impact of their intervention on treatment expenditures. There was significant change in the pattern of use of antimicrobials, this pattern approximating that of a medical-surgical ICU that participates in the ICARE (Intensive Care Antimicrobial Resistance Epidemiology) Project. For example, there was a significant increase in the consumption of antimicrobials of the ampicillin group (Relative Risk [RR]=3.39; 95% CI: 2.34-4.91) and antipseudomonal penicillins (RR=2.89; 95% CI: 1.70-4.92). On the other hand, there was a significant reduction in the consumption of 3rd/4th generation cephalosporins (RR=0.66; 95% CI: 0.57-0.77) and carbapenems (RR=0.43; 95% CI: 0.33-0.56). On average, for every patient-day antibiotic expense was reduced 37.2% during calendar year 2001, when compared with 2000. The ID specialists' opinion and the adoption of guidelines for empirical antibiotic therapy of hospital-acquired pneumonia contributed to a reduction in the use of antimicrobials in medical-surgical ICU. However, further studies that have more control over confounding variables are needed to help determine the relevance of these discoveries.
publishDate 2003
dc.date.none.fl_str_mv 2003-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702003000500002
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702003000500002
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1413-86702003000500002
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
dc.source.none.fl_str_mv Brazilian Journal of Infectious Diseases v.7 n.5 2003
reponame:Brazilian Journal of Infectious Diseases
instname:Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
instname_str Brazilian Society of Infectious Diseases (BSID)
instacron_str BSID
institution BSID
reponame_str Brazilian Journal of Infectious Diseases
collection Brazilian Journal of Infectious Diseases
repository.name.fl_str_mv Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)
repository.mail.fl_str_mv bjid@bjid.org.br||lgoldani@ufrgs.br
_version_ 1754209238631055360